A detailed history of Ares Financial Consulting, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ares Financial Consulting, LLC holds 21,026 shares of PFE stock, worth $527,332. This represents 0.5% of its overall portfolio holdings.

Number of Shares
21,026
Holding current value
$527,332
% of portfolio
0.5%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026

BUY
$24.23 - $27.37 $509,459 - $575,481
21,026 New
21,026 $524 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ares Financial Consulting, LLC Portfolio

Follow Ares Financial Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ares Financial Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ares Financial Consulting, LLC with notifications on news.